650 Management
Refine
Year of publication
- 2018 (36) (remove)
Document Type
- Journal article (14)
- Book chapter (12)
- Book (5)
- Conference proceeding (4)
- Working Paper (1)
Is part of the Bibliography
- yes (36)
Institute
- ESB Business School (24)
- Informatik (8)
- Life Sciences (2)
- Texoversum (2)
Publisher
- Springer (11)
- Haufe (4)
- MIT Center for Information Systems Research (4)
- RWTH Aachen (3)
- Schäffer-Poeschel (3)
- UVK Verlagsgesellschaft (2)
- Elsevier (1)
- Fraunhofer-Verbund Innovationsforschung (1)
- Hanser (1)
- IDL GmbH Mitte (1)
A case study with four German fashion retail brands was conducted in order to measure the performance of their Omnichannel services. In detail, their Click & Collect service was analyzed. Click & Collect is one of the first introduced Omnichannel services in fashion retailing. Omnichannel services integrate different sales and communication channels providing a seamless customer journey experience. Offline, online, and mobile app customer experiences should provide a seamless customer experience. Omnichannel performance of the four retailers Decathlon, Hunkemöller, Massimo Dutti and Galeria Kaufhof was measured via mystery shopping. A seamless customer journey experience is not yet a standard in German fashion retailing. The four companies differ in many process details. The biggest market potential and the recommendation for further research emerges in deficits of the offline store Omnichannel customer experience. Here, all four case companies have room to improve. Best overall results regarding the integration of offline, online and mobile shops were found with Hunkemöller, followed by Decathlon, Massimo Dutti, and Galeria Kaufhof.
Marketing ist allgegenwärtig! Es begegnet Ihnen im Supermarkt, in Onlineshops und in sozialen Medien. Doch was steckt konkret hinter dem Marketing und wie gestalten Unternehmen es erfolgreich? Auf diese und weitere Fragen geht das Buch im Detail ein. Zu Beginn vermittelt es Grundlagen zum Konsumentenverhalten, zum Kaufprozess und zur persönlichen Kaufentscheidung. Vor diesem Hintergrund erläutert es Ziele und Maßnahmen der strategischen Marketingplanung. Darauf aufbauend präsentiert es Aspekte einer operativen Marketingplanung und diskutiert die Marken-, Produkt-, Distributions-, Kommunikations- sowie Preispolitik ausführlich. Marketingprofis geben Einblicke in die Praxis. Ein Best Practice-Beispiel macht das Gelernte schnell (be)greifbar.
Nachdem Unternehmen Klarheit über das Kundenverhalten und die damit zusammenhängenden Determinanten haben, gilt es, in einem zweiten Schritt eine Strategie auszuarbeiten, die die bestmögliche Befriedigung der Kundenbedürfnisse in den Mittelpunkt des Handelns setzt. Je besser dieses den Unternehmen gelingt, umso besser lassen sich damit deren eigene Ziele verwirklichen. Dabei gilt es zunächst, einen Marketingplan zu entwickeln.
Customer relationship management (CRM) is one of the most frequently adopted management tools and has received much attention in the literature. From a company-wide perspective, CRM is viewed as a complex process requiring interventions in different company areas. Previous research has already highlighted the pitfalls and failures related to a partial and incomplete view of CRM. This study advances research on CRM by investigating the impact of the relative implementation time according to which interventions are implemented in different areas (customer management, CRM technology, organizational alignment, and CRM strategy) on CRM performance. The results of the empirical study reveal that compared to other critical CRM activities, a later implementation of organizational alignment activities has a negative impact on performance. Further, our results show that CRM implementations do not equally address the areas of customer acquisition, growth, and loyalty, since this clearly depends on company objectives and also on geographical differences.
Historically, research and development (R&D) in the pharmaceutical sector has predominantly been an in-house activity. To enable investments for game changing late-stage assets and to enable better and less costly go/no-go decisions, most companies have employed a fail early paradigm through the implementation of clinical proof-of-concept organizations. To fuel their pipelines, some pioneers started to complement their internal R&D efforts through collaborations as early as the 1990s. In recent years, multiple extrinsic and intrinsic factors induced an opening for external sources of innovation and resulted in new models for open innovation, such as open sourcing, crowdsourcing, public–private partnerships, innovations centres, and the virtualization of R&D. Three factors seem to determine the breadth and depth regarding how companies approach external innovation: (1) the company’s legacy, (2) the company’s willingness and ability to take risks and (3) the company’s need to control IP and competitors. In addition, these factors often constitute the major hurdles to effectively leveraging external opportunities and assets. Conscious and differential choices of the R&D and business models for different companies and different divisions in the same company seem to best allow a company to fully exploit the potential of both internal and external innovations.
This book investigates and highlights the most critical challenges the pharmaceutical industry faces in an increasingly competitive environment of inflationary R&D investments and tightening cost control pressures. The authors present three sources of pharmaceutical innovation: new management methods in the drug development pipeline; new technologies as enablers for cutting-edge R&D; and new forms of cooperation and internationalization, such as open innovation in the early phases of R&D. New models and methods are illustrated with cases from Europe, the US, and Asia. This third fully revised edition was expanded to reflect the latest updates in open and collaborative innovation, the greater strategic importance of venture capital and early stage investments, and the new range of emerging technologies now being put to use in pharmaceutical innovation.
Vor dem Hintergrund, dass aktuell erstmals konzeptionelle Grundlagen für ein Nachhaltigkeitsmanagement in außeruniversitären Forschungseinrichtungen entwickelt worden sind, sollen nun diese Ergebnisse in die Konzeption eines interdisziplinären und organisationsübergreifenden Ansatzes zur Integration von Nachhaltigkeitsaspekten in Lehre und Weiterbildung einfließen. Die empirische Grundlage bildet eine qualitative, organisationsethnografische Fallstudie, in der die Autoren Deutungen von Experten und Expertinnen sowie deren Betriebs- und Alltagswissen in Bezug auf ein nachhaltiges Personalmanagement untersuchen. Auf Basis der daraus entwickelten praktischen Implementierungsmöglichkeiten in außeruniversitären Forschungseinrichtungen soll nun ein Ansatz entwickelt werden, um die Ergebnisse auf die Lehre in Hochschulen und die interorganisatorische Weiterbildung von Forschungseinrichtungen zu übertragen.
Relocation of production to countries with low labour costs has induced increased labour market flexibility, which has been praised as a silver bullet for economic growth and low unemployment. Within a unionised oligopoly framework, in which a multinational firm has the option to relocate its production to a foreign country, we analyse the welfare implications of both centralised and flexible wage-setting regimes. For very low foreign wages, wage flexibility leads to higher welfare than a rigid centralised regime. In contrast, for ‘intermediate’ wage levels in the foreign country, an industry-wide uniform wage leads to higher social welfare than flexible wages.